Introduction
Elevation of copper in the serum of tumor-bearing animals as well as in humans with primary tumours of different localisation have been reported earlier [1, 2] , These results also reflected the usefulness of raised serum copper concentration in determining the activity of the disease. Therefore to study the importance of this measurement in prognosis, serum copper was determined in the tumour bearing mice both before and after treatment with chemothera peutic drugs. It was carried out in animal tumour system first, because the clinical evidence of a therapeutic advantage established with animal tumours, can suitably be incorporated into clinical practice. To further investigate the correlation, the tissue copper concentration was also determined both before and after treatment with chemothera peutic regimens.
Materials and Method

Establishment of tumour
All experiments were carried out in male strain A/ RB mice.
The solid tumour was developed by the inocula tion of 0.3 ml of 0.133 percent benzo(a)pyrene sus pension in olive oil into the right thigh of 100 mice.
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Tumour growth was detected 3-4 months after in oculation in about 50 percent of the mice. Histologi cal studies of the tumour tissue showed a fibrosarcomatous appearance.
Chemotherapy of tumour
(1) 5-Fluorouracil obtained from the Sigma Chem ical Company was dissolved in physiological saline and injected in a dose of 25 mg/kg body weight for 7 consecutive days [3] . Ten normal and ten tumour bearing mice received the injection. After 3 to 4 days of the anticancer drug treatment, the tumour volume was measured using the formula n x D^D iX D ? where Dj, D2, and D3 denotes the length, breadth and height of the tumour (4). The blood was col lected from the mice by slitting the jugular vein. The serum was separated and analyzed for copper by Atomic Absorption Spectrophotometer.
(2) 2 mg mitomycin C obtained from the Sigma Chemical Company was dissolved in 0.8 ml of methanol and then diluted to desired concentration with physiological saline. The solution was prepared on 1st day of the week and stored for use through-out the week. The dose given was 8.4 mg per kg body weight. Ten tumour bearing mice as well as ten nor mal strain A mice received the drug. The whole dose was given in two separate injections at intervals of 7 days. After treatment, when regression of tumour size was visible, the tumour volume was measured. The normal, untreated as well as treated mice were killed by slitting the jugular vein. From the blood collected serum was separated. The serum copper concentration was determined by Atomic Absorp tion Spectrophotometer in both control and tumour bearing animals. The liver as well as the tumour tis sue were also dissected out from the mice homogen ized in 0.25 m sucrose solution and the tissue copper was also estimated by Atomic Absorption Spectro photometer. For control study of tumour tissue, homologous tissue from the same site was taken from normal mice. Table I shows the tumour volume before and after treatment with anti-cancer drugs. The table shows that there is significant regression in tumour volume following treatment with both mitomycin C and 5-fluorouracil. The regression in case of mitomycin C treated mice was 76 percent and in 5-fluorouracil treated mice it was 57 percent, compared to un treated condition.
Results
In Table II , the serum copper concentration is shown both before and after treatment. The serum copper concentration which was raised as a result of tumour growth, was again depressed after successful treatment with both drugs. It was 50 percent in mitomycin treated mice and 32 percent in case of 5-fluorouracil treated mice, compared to their untreat ed condition. Table III and Fig. 1 gives the tissue copper con centration before and after treatment with anti cancer drugs. It is also observed that though the tumour had regressed to a great extent, there was little change in the copper concentration in liver of treated mice compared to untreated condition. How ever, in the tumour tissue a striking reduction in cop per concentration was noticed. The tissue copper concentration which was greatly increased as a result of tumour formation, fell significantly after treat ment suggesting a positive correlation with the tumour burden. 
Discussion
Earlier studies have revealed that the serum cop per concentration is correlated with disease activity in human cancer patients and also in mice bearing different types of tumours [1, 2] . Interestingly, in this study the measurement of Serum copper in experi mental mice made after successful treatment with anticancer drugs under controlled conditions re vealed that along with tumour regression there was significant depression in serum copper concentra tion. Such results have been reported earlier in hu man patients with tumour of different sites [1] ,
The correlation of copper concentration with tumor regression was also well demonstrated by re duced copper concentration observed in tumour tis sue after successful treatment. The tissue copper concentration which was elevated with the develop ment of tumour, was again depressed almost to the normal range with reduction of the tumour volume. However, there was hardly any change in the copper concentration of the liver of tumour bearing mice after successful treatment with anti-cancer drugs. This seems to be due to the disturbance in the liver functions with the development of tumour [5] , Thus the serum copper concentration seems to have direct correlation with tumour regression, and it can be of substantial help in determining remission of the disease in mice bearing induced fibrisarcoma.
